Documents / Report

Defense Intelligence Reference Document Biosensors And A Survey Of The Present Field

Defense Intelligence Agency · 45 pages · text from the file's own layer

This Defense Intelligence Agency reference document, dated 31 March 2010 (DIA-08-1003-020), was one of a series of advanced technology reports produced in FY 2009 under the Advanced Aerospace Weapon System Applications (AAWSA) program. It surveys biosensors and BioMEMS, covering brain-implanted neuroelectrodes, drug-delivery pumps, implantable glucose sensors, brain-machine interfaces, retinal prostheses, microfluidic lab chips, NASA cell culture systems, and microcantilever sensors. It concludes that the field is expanding rapidly toward nanomechanical systems.

  • p. 2 …a series of advanced technology reports produced in FY 2009 under the Defense Intelligence Agency, J…
  • p. 6 …This paper examines some of the most recent advances in the field, as well as the…
  • p. 7 …Advanced systems can perform several tests on the sample at one time. There are also drug…
  • p. 10 …This is the idea behind advanced devices that allow quadriplegics to interact with their environment. Signals…
  • p. 14 …There has been the application of MEMS technologies in the creation of better ways to deliver…
  • p. 19 …The human body is an exceptionally hostile environment for foreign materials. Even our most advanced biosensors…
  • p. 21 …sensor using this kind of approach (Advanced Biosensors Inc). The fine needle geometry is generally meant…
  • p. 45 …The economic driving forces for this miniaturization are strong for health care and biology. Advanced fabrication…
UNCLASSIFIED/ ,~F&R: &FFHiIAL Wili &HLY
Figure 27. Power Transfer by Magnetic Induction to an Implanted BioMEMS Retinal Prosthesis. This is
the Boston Retinal Implant Project.
(http://www.bostonretinalimplant.org/retinalapproach.php?fontsize=normal&hicontrast)
MICROSCALE IN THERAPEUTIC NEUROSTIMULATION
Some of the biggest excitement in medical neuroprosthetics has been in the notion that
we can use micro-implantable devices rather than drugs to reduce or better control the
effects of stroke, heart disease, epilepsy, and other disorders of the human condition.
Bioelectrical stimulation has effects which are very specific on local tissues rather than
indiscriminately affecting all tissues and so may offer fewer side effects of drugs. Such
devices can be finely controlled in their effects and provide a greater flexibility in terms
of treatment.
Any implanted device has to be small in order to be minimally invasive, especially in the
brain. Powering of implanted devices by batteries is only practical in a few biomedical
situations. Also implants may need to communicate with the outside world wirelessly.
Having wires penetrating the skin is uncomfortable and could lead to infection in the
tissue.
The notion of placing bioelectronic stimulation devices inside of the body for therapeutic
reasons goes back to the early invention of the pacemaker. These kind of devices have
internal batteries to support an electrical pulse generator that paces the rhythm of the
heart.
Because the amount of energy in each pulse is relatively small the power drain is low
and the pacemaker batteries can last years. The difficulty is that they are bulky, must
be eventually replaced on the order of seven years, and their placement is invasive.
30
UNCLASSIFIED/ ,'1"91t 91"1"1!111.L tl!IL 9HL I

Not linked to a story yet.

About this file

Report, from the dia collection. The PDF is mirrored here; the original link is above. 45 pages are in the text index: search them above, or from the library's search.